Ampa Inc.

Ampa develops accessible neuromodulation technology for mental health care, led by its FDA-cleared Ampa One portable TMS system for adult major depressive disorder. The system combines camera-guided neuronavigation, lightweight hardware, rapid setup, and a subscription-based model to help clinics expand treatment capacity without upfront equipment costs.